Disease-free survival as a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a meta-analysis of 20 randomized controlled trials

Disease-free survival as a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a meta-analysis of 20 randomized controlled trials

Abstract Background We aimed to assess whether disease-free survival (DFS) could serve as a reliable surrogate endpoint for overall survival (OS) in adjuvant trials of pancreatic cancer. Methods We systematically reviewed adjuvant randomized trials for non-metastatic pancreatic cancer after curative...

Full description

Bibliographic Details
Main Authors: Run-Cong Nie, Xue-Bin Zou, Shu-Qiang Yuan, Ying-Bo Chen, Shi Chen, Yong-Ming Chen, Guo-Ming Chen, Xiao-Jiang Chen, Tian-Qi Luo, Shu-Man Li, Jin-Ling Duan, Yun Wang, Yuan-Fang Li
Format: Article
Language:English
Published: BMC 2020-05-01
Series:BMC Cancer
Subjects:
Pancreatic cancer
Disease-free survival
Overall survival
Surrogate
Online Access:http://link.springer.com/article/10.1186/s12885-020-06910-5

Internet

http://link.springer.com/article/10.1186/s12885-020-06910-5

Similar Items